Development of Celiac Disease Therapeutics: Report of the Third Gastroenterology Regulatory Endpoints and Advancement of Therapeutics Workshop
Gastroenterology
.
2016 Sep;151(3):407-11.
doi: 10.1053/j.gastro.2016.07.025.
Epub 2016 Jul 25.
Authors
Daniel Leffler
1
,
Sonia S Kupfer
2
,
Benjamin Lebwohl
3
,
Kevin Bugin
4
,
Donna Griebel
4
,
Julia Tait Lathrop
4
,
Jessica J Lee
4
,
Andrew E Mulberg
4
,
Elektra Papadopoulos
4
,
Juli Tomaino
4
,
Sheila E Crowe
5
Affiliations
1
Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
2
Department of Medicine, University of Chicago, Chicago, Illinois.
3
Department of Medicine, Columbia University, New York, New York.
4
US Food and Drug Administration, Silver Spring, Maryland.
5
Department of Medicine, University of California San Diego, La Jolla, California. Electronic address:
[email protected]
.
PMID:
27456385
DOI:
10.1053/j.gastro.2016.07.025
No abstract available
Publication types
Congress
Research Support, Non-U.S. Gov't
MeSH terms
Celiac Disease / drug therapy*
Drug Approval*
Drug Evaluation*
Humans
Pharmaceutical Research / trends*